Loading EKSO total return...
Loading summary...

About EKSO Dividend Returns

Ekso Bionics Holdings, Inc. (EKSO) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of EKSO over the past year?

Ekso Bionics Holdings, Inc. (EKSO) delivered a total return of 79.33% over the past year when dividends are reinvested. The price-only return was 79.33%, meaning dividends contributed an additional 0.00 percentage points to total returns.

Q2How much would $10,000 invested in EKSO be worth today?

A $10,000 investment in Ekso Bionics Holdings, Inc. one year ago would be worth $17,933 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $17,933. Dividend reinvestment added $0 to the portfolio value.

Q3Does EKSO pay dividends?

Yes, Ekso Bionics Holdings, Inc. (EKSO) pays dividends. In the last year, EKSO paid approximately $0.09 per share in dividends (0.79% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did EKSO beat the S&P 500?

Yes, Ekso Bionics Holdings, Inc. (EKSO) outperformed the S&P 500 by 48.96 percentage points over the past year. EKSO delivered a total return of 79.33%, compared to the S&P 500's 30.37%. This 48.96pp alpha means investors in EKSO earned more than a passive S&P 500 index fund.

Q5What is EKSO's worst drawdown?

Ekso Bionics Holdings, Inc. (EKSO) experienced a maximum drawdown of -61.16% over the past year, declining from its peak on 2025-05-14 to its trough on 2025-06-23. The stock recovered to its prior peak by 2025-12-30. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is EKSO's long-term total return over 10, 20, or 30 years?

Here are Ekso Bionics Holdings, Inc. (EKSO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.3% (-38.7% CAGR) — $10,000 would have grown to $75. Over 20 years: -99.7% total return (-25.0% CAGR) — $10,000 → $32. Over 30 years: -99.7% total return (-17.4% CAGR) — $10,000 → $32. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was EKSO's best and worst year?

Ekso Bionics Holdings, Inc.'s best calendar year was 2023 with a total return of 89.4%. Its worst year was 2024 with a total return of -80.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 169.7 percentage points.

💰

Find the Best Dividend Stocks

Screen for dividend stocks with the highest total returns (including DRIP).

View Dividend Stocks →

Compare Similar Stocks

Deep Dive into EKSO